Evidence map›Paper›PMID 40568327›Full record

ArticleWorld journal of nephrology2025

Epidemiological trends in diabetic renal complications in United States adults: A center for disease control and prevention wide-ranging online data for epidemiologic research analysis (1999-2020).

Abdullah Naveed Muhammad, Faizan Ahmed, Sherif Eltawansy, Ahila Ali, Bazil Azeem, Muhammad Kashan, Zaima Afzaal, Mushood Ahmed, Kainat Aman, Aman Amanullah and 3 more

Abstract read
In one paragraph

Article in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. [Burden of Diabetic Kidney Disease at Global, Regional, and National Levels From 1990 to 2021].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Abdullah Naveed MuhammadDepartment of Internal Medicine, Dow Medical College, Karachi 74200, Sindh, Pakistan.
Faizan AhmedDepartment of Cardiology, Duke University Hospital, Durham, NC 27710, United States.
Sherif EltawansyDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, United States. alanine40@hotmail.com.
Ahila AliDepartment of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi 74900, Sindh, Pakistan.
Bazil AzeemDepartment of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi 74900, Pakistan.
Muhammad KashanDepartment of Internal Medicine, Dow Medical College, Karachi 74200, Sindh, Pakistan.
Zaima AfzaalDepartment of Internal Medicine, Services Institute of Medical Sciences, Lahore 54000, Punjab, Pakistan.
Mushood AhmedDepartment of Internal Medicine, Rawalpindi Medical University, Rawalpindi 74200, Pakistan.
Kainat AmanDepartment of Internal Medicine, Batterjee Medial College, Jeddah 21442, Saudi Arabia.
Aman AmanullahDepartment of Internal Medicine, SSM Health St Louis University, St Louis, MO 63104, United States.
Muhammad Naveed Uz ZafarDepartment of Internal Medicine, Liaquat Institute of Medical and Health Sciences, Thatta 73130, Sindh, Pakistan.
Pawel LajczakDepartment of Biophysics, Medical University of Silesia in Katowice, Katowice 40-055, Poland.
Ogechukwu ObiDepartment of Internal Medicine, New York Institute of Technology, College of Osteopathic Medicine, Westbury, NY 11568, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal complications of diabetes mellitus pose a significant public health challenge, contributing to substantial morbidity and mortality globally. Understanding temporal trends and regional disparities in mortality related to diabetic nephropathy is crucial for guiding targeted interventions and policy decisions.

aimTo display the trends and disparities of diabetic nephropathy related mortality.

methodsA retrospective analysis was conducted using death certificate data from the center for disease control and prevention (CDC) wide-ranging online data for epidemiologic research analysis (WONDER) database, spanning from 1999 to 2020, to investigate mortality related to renal complications of diabetes in adults aged 35 or above. Age-adjusted mortality rate (AAMR) per 100000 persons and annual percent change (APC) were computed, with stratification by year, sex, race/ethnicity, and geographic region.

resultsBetween 1999 and 2020, a total of 525804 deaths occurred among adults aged 35 to 85+ years due to renal-related issues associated with diabetes. AAMR for renal-related deaths in adult diabetic patients showed a consistent increase from 1.6 in 1999 to 34.9 in 2020 (average APC [AAPC]: 17.23; 95% confidence interval [CI]: 13.35-28.79). Throughout the study period, men consistently had higher AAMR (overall AAMR for men: 17.8; 95%CI: 17.7-17.9). In 1999, the AAMR for men was 1.8, increasing to 44.2 by 2020 (AAPC: 17.54; 95%CI: 13.09-29.53), while for women, it was 1.6 in 1999 and rose to 27.6 by 2020 (AAPC: 15.55; 95%CI: 13.35-21.10). American Indian/Alaska Native adults exhibited the highest overall AAMR (36.1; 95%CI: 35.2-36.9), followed by Black/African American (25.5; 95%CI: 25.3-25.7). The highest mortality was observed in the Western (AAMR: 16.6; 95%CI: 16.5-16.7), followed by the Midwestern region (AAMR: 14.4; 95%CI: 14.314.4). Significant variations in AAMR were observed among different states, with Oklahoma recording the highest (21.2) and Connecticut the lowest (7). The CDC WONDER database could potentially have omissions or inaccuracies. It does not provide data outside of the available variables. Furthermore, dataset after 2020 was not included in this study.

conclusionOur findings highlight an alarming rise in mortality related to renal complications of diabetes among United States adults over the past two decades, with concerning disparities across demographic and geographic factors. These results underscore the urgent need for targeted interventions, policies, and protocols to address the growing burden of diabetic nephropathy and substantially reduce mortality rates in the United States. This will help improve the overall health outcome in the United States by identifying communities at risk and implementing tailored assistance to them.

Indexed as

Chronic diseaseComorbidityDiabetes mellitusKidney diseasesMortality

Identifiers

PMID40568327
PMCPMC12001215

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.